BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26976204)

  • 1. Serum Vitamin D is Not Helpful for Predicting Prostate Cancer Aggressiveness Compared with the Prostate Health Index.
    Stephan C; Lein M; Matalon J; Kilic E; Zhao Z; Busch J; Jung K
    J Urol; 2016 Sep; 196(3):709-14. PubMed ID: 26976204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml.
    Ito K; Yokomizo A; Tokunaga S; Arai G; Sugimoto M; Akakura K; Hasumi H; Sakai H; Ouraji A; Oki R; Kashiwagi E; Kobori Y; Hirama H; Kitoh H; Uemura H; Hakariya T; Suzuki K;
    J Urol; 2020 Jan; 203(1):83-91. PubMed ID: 31430244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysis.
    Berg KD; Thomsen FB; Nerstrøm C; Røder MA; Iversen P; Toft BG; Vainer B; Brasso K
    BJU Int; 2016 Jun; 117(6):883-9. PubMed ID: 26823232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ability of Prostate Health Index (PHI) to Predict Gleason Score in Patients With Prostate Cancer and Discriminate Patients Between Gleason Score 6 and Gleason Score Higher Than 6-A Study on 320 Patients After Radical Prostatectomy.
    Dolejsova O; Kucera R; Fuchsova R; Topolcan O; Svobodova H; Hes O; Eret V; Pecen L; Hora M
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818787377. PubMed ID: 30021484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D deficiency predicts prostate biopsy outcomes.
    Murphy AB; Nyame Y; Martin IK; Catalona WJ; Hollowell CM; Nadler RB; Kozlowski JM; Perry KT; Kajdacsy-Balla A; Kittles R
    Clin Cancer Res; 2014 May; 20(9):2289-99. PubMed ID: 24789033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.
    Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
    Int J Cancer; 2012 Sep; 131(5):1187-96. PubMed ID: 22033893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer.
    Guazzoni G; Lazzeri M; Nava L; Lughezzani G; Larcher A; Scattoni V; Gadda GM; Bini V; Cestari A; Buffi NM; Freschi M; Rigatti P; Montorsi F
    Eur Urol; 2012 Mar; 61(3):455-66. PubMed ID: 22078333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.
    Samaratunga H; Delahunt B; Yaxley J; Srigley JR; Egevad L
    Scand J Urol; 2016 Oct; 50(5):325-9. PubMed ID: 27415753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Serum Testosterone But Not Obesity Predicts High Gleason Score at Biopsy Diagnosed as Prostate Cancer in Patients with Serum PSA Lower than 20 ng/ml.
    Shiota M; Takeuchi A; Sugimoto M; Dejima T; Kashiwagi E; Kiyoshima K; Inokuchi J; Tatsugami K; Yokomizo A
    Anticancer Res; 2015 Nov; 35(11):6137-45. PubMed ID: 26504040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
    Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
    Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study.
    Bryant RJ; Sjoberg DD; Vickers AJ; Robinson MC; Kumar R; Marsden L; Davis M; Scardino PT; Donovan J; Neal DE; Lilja H; Hamdy FC
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor marker α-fetoprotein receptor does not discriminate between benign prostatic disease and prostate cancer.
    Smrkolj T; Gubina B; Bizjak J; Kumer K; Fabjan T; Osredkar J
    Adv Clin Exp Med; 2017 Oct; 26(7):1085-1090. PubMed ID: 29211355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHI in the Early Detection of Prostate Cancer.
    Fuchsova R; Topolcan O; Windrichova J; Hora M; Dolejsova O; Pecen L; Kasik P; Novak J; Casova M; Smejkal J
    Anticancer Res; 2015 Sep; 35(9):4855-7. PubMed ID: 26254378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association among plasma 1,25(OH)
    Ramakrishnan S; Steck SE; Arab L; Zhang H; Bensen JT; Fontham ETH; Johnson CS; Mohler JL; Smith GJ; Su LJ; Woloszynska A
    Prostate; 2019 Jul; 79(10):1117-1124. PubMed ID: 31077420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of Prostate Health Index in Biopsy Naïve Black Men.
    Babajide R; Carbunaru S; Nettey OS; Watson KS; Holloway-Beth A; McDowell T; Ben Levi J; Murray M; Stinson J; Hollowell CMP; Dalton DP; Moore L; Kittles RA; Gann PH; Schaeffer EM; Murphy AB
    J Urol; 2021 Mar; 205(3):718-724. PubMed ID: 33103942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gleason inflation 1998-2011: a registry study of 97,168 men.
    Danneman D; Drevin L; Robinson D; Stattin P; Egevad L
    BJU Int; 2015 Feb; 115(2):248-55. PubMed ID: 24552193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D, PTH, and calcium and tumor aggressiveness in prostate cancer: a prospective nested case-control study.
    Brändstedt J; Almquist M; Ulmert D; Manjer J; Malm J
    Cancer Causes Control; 2016 Jan; 27(1):69-80. PubMed ID: 26518197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
    Epstein JI; Amin MB; Reuter VE; Humphrey PA
    Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer.
    Samaratunga H; Delahunt B; Gianduzzo T; Coughlin G; Duffy D; LeFevre I; Johannsen S; Egevad L; Yaxley J
    Pathology; 2015 Oct; 47(6):515-9. PubMed ID: 26325670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.